Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
With
Kurosawa Hospital
OBJECTIVES:
* To determine the efficacy of permanent brachytherapy with iodine I 125 seeds in patients with localized prostate cancer.
* To determine the safety of this therapy in these patients.
OUTLINE: This is a multicenter study.
Patients undergo permanent brachytherapy seed implantation comprised of iodine I 125 into the prostate. Some patients may receive combination treatment (e.g., external beam radiation therapy (EBRT) or hormone therapy in addition to brachytherapy).
Quality of life and the International Prostate Symptom Score (IPSS) is assessed and compared.
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
DISEASE CHARACTERISTICS:
Clinically and histologically confirmed localized prostate cancer
PATIENT CHARACTERISTICS:
Not specified
PRIOR CONCURRENT THERAPY:
No prior or concurrent surgery
No prior or concurrent radiotherapy
Prior chemotherapy, hormonal therapy, and biologic therapy allowed
Clareo Health | Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
